BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 22519158)

  • 41. Timing of blood sampling for CD4 T-cell counting influences HAART decisions.
    Bekele Y; Mengistu Y; de Wit TR; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):187-97. PubMed ID: 21991752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.
    Tesfaye Z; Enawgaw B
    BMC Res Notes; 2014 Oct; 7():745. PubMed ID: 25335859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settings.
    Argemi X; Dara S; You S; Mattei JF; Courpotin C; Simon B; Hansmann Y; Christmann D; Lefebvre N
    AIDS; 2012 Jun; 26(9):1161-6. PubMed ID: 22472856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study.
    Mesfin N; Deribew A; Yami A; Solomon T; Van Geertruyden JP; Colebunders R
    Int J STD AIDS; 2012 Feb; 23(2):94-8. PubMed ID: 22422682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
    Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
    J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of T CD4 lymphocyte levels and chronic periodontitis in HIV-infected brazilian patients undergoing highly active anti-retroviral therapy: clinical results.
    Gonçalves LS; Ferreira SM; Silva A; Villoria GE; Costinha LH; Colombo AP
    J Periodontol; 2005 Jun; 76(6):915-22. PubMed ID: 15948685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
    Ndlovu Z; Chirwa T; Takuva S
    Pan Afr Med J; 2014; 19():114. PubMed ID: 25722787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia.
    Eshetu A; Tsegaye A; Petros B
    Biol Trace Elem Res; 2014 Dec; 162(1-3):106-12. PubMed ID: 25256923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4(+) T-cell recovery after initiation of antiretroviral therapy in a resource-limited setting: a prospective cohort analysis.
    Kanters S; Nachega J; Funk A; Mukasa B; Montaner JS; Ford N; Bucher HC; Mills EJ
    Antivir Ther; 2014; 19(1):31-9. PubMed ID: 23963170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No association of cryptococcal antigenemia with poor outcomes among antiretroviral therapy-experienced HIV-infected patients in Addis Ababa, Ethiopia.
    Smitson CC; Tenna A; Tsegaye M; Alemu AS; Fekade D; Aseffa A; Blumberg HM; Kempker RR
    PLoS One; 2014; 9(1):e85698. PubMed ID: 24465651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y; Liu H; Zhang S; Zhang Y; Wang H; Zhang H; Li X
    BMC Infect Dis; 2024 May; 24(1):514. PubMed ID: 38778273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
    de Jong MA; Wisaksana R; Meijerink H; Indrati A; van de Ven AJ; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2012 May; 17(5):581-3. PubMed ID: 22364582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.